| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | Giardia lamblia ATCC 50803 Liver stage antigen-like protein |
| | (a.a.61-460) |
| | Swiss-Prot #: | A8B344 |
| | Entry name: | A8B344_GIALA |
| | Protein | Liver stage antigen-like protein |
| | Gene names: | GL50803_16595 |
| | Organism: | Giardia lamblia ATCC 50803 |
| | Codon-optimized cDNA Clone |
| | Cat#: | RPL-0281 |
| | Description: | Applications:1. Codon-optimized cDNA sequence designed for recombinant |
| | protein production in both E.coli and Mammalian cell. The cDNA has been |
| | cloned into E.coli expression vector with 6x Histidine tag. 2. May be used as |
| | RNAi assistance to restore the loss-of-function. |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Recombinant Protein |
| | Cat#: | PL-0281 |
| | Source: | Recombinant protein derived from E.coli. Or Yeast |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Purity: | > 90%, as determined by SDS-PAGE under reducing conditions |
| | Activity: | N/A |
| | Applications: | Western Blot, may be used for other applications determined by |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Sequence: | | MEDIAYTDGY AAQYGDNYAY DGYGYGGDLA VGDYNPYGTD YGYDAGGYDY GAGYGGYGNQ ETGYGDQTYG YGEPAEQPQD |
| | SLSLKLDEPK PFTEQDDGRS LVVRTDAASV SMDPFSAPID TVTEPIGSQT HTSSAFPPVS QDLLNSIRVQ QETSGNLSKS |
| | PSKISSRPAS ARLDELDKVI EEDAEQLNRE AKTDTHVTGA APDTSDMFGF TDQPAAPTAT EEPVATAGDD MFGFGLESDA |
| | HDATVQPPVE DAGPALPDKE APSTEAEDDM FGFATSPQET IASPPAGSTA PAAEPVDDMF GFTDPAVESA ATAEPGTMEG |
| | DDMFGFGPSE STPKDPDTDA SAVAKDVTVD AQDAADDMFG FDGAGSPAEA PAQSTEAVAS PVADLETDSM FGFDSPPAPA |
| | DNTTTVPVDD SADDLFGFGP STLDAQGEPA QDAQPDIQDV AQVSADSMFG FDLPADASAT VEPSTTGLAT EKPEDSPVDD |
| | MFGFSPNEAA ATAKSDEDQE ITPVNTKTLD EPLSVANDYT QPTAGPSDDM FGFGNSADLP QTDSVPHSGA TADSMFGFDS |
| | VPATGASVEP PTETPELHDA SQTQPTLDMP TIPEHIPTIE DNQTDLSHES QNESQVASEE SDQLRETNET LEGEEMNKEL |
| | AQEPAVEDMF GFGDASAPVE DSSTEKATES HPTEPPNLAD LPPPVSASSL LPVQTLESAK QSARAATTPV ADMAIDIDSM |
| | ISAALVPQQP SPAPEQKVED QVLDESSPNV ITAELPPIVV KGSLEEANDK SAAESQHEPV ELSEDRDLSK DIELVAQDPL |
| | PAEEDTQDIF VEPAVPVEAL ERLAISETFI KLQEELQFTY LMPEPNREEL DKLQMTDHEQ QLIQLKDEAE RLQRENKVLA |
| | GRSAAPRHLH PNEFDSKSIS VSFFEGLLNE PTHSDGISLT TGEELRLLAI LEQGDYEALD ALHGMSPEEL QLMEQREREF |
| | NLKLKELTDR RDELLYKDDT EALKLIEEEI WAFVDAEEEK KMRIQAADDL LKKRAQEEED RRRAEIEAKI KEEQDRVAEE |
| | RRLQEEMIAL QKKQQQEYAE QETRKADLLR EAMEKEQLER IEEEQRIKAE ARRRLIDDLE ATAERAAAED RIRVKAELEE |
| | MARIKKELEE AARTASEEKR KLLLQQKEQL EREMAETARR HEEDVARRHK ELQTLHEERR KMREQRLASS EPMDELLRED |
| | GNDASADPFS YASLDIERRI REMKAQLEKE MTEKMALEHA DLNALEQELA AKKLSTLQAE RLLSTAASDT VARLDNEDRL |
| | FNEAMDAKRQ ELLLLKEQYG LVRHQNESQR ALHLEEQRKA KKLARLVEQV AELAEKKHNL ERKIAHGNKE FHKKESKLVA |
| | SNSKGALKAL RKEHAKEHEA LETQLSSVSE QLRRAKKQLK VLNPQGETSD MDRSLSVKDY LRSTDRSEKE QEVSAADKDH |
| | SQPRLSVFEG GSLGQPSLVS GHGIGTAMST GVDHGDGGRK QHASSDLPVA LQKLREEHAR RLEKIEQRRA AFASEREQLQ |
| | AQAHALEAQL SKPVNVPDSK LRTREQRKQI IFAEMNRMEK LSKAHMVEVK PQIPEKTIDD ILNERRKRHG EEREQLKNMA |
| | VRFTSAYDRH SRVSVNMDSS DDEWNDLAAR TSSRYADISA KPRSMQAQVR QFASDRIDPA FNSYIEAPVR PGYESSLLSY |
| | For pricing and availability Click Here >>> |
| | Recombinant-Protein-cDNA-Liver-stage-antigen-like-protein-Giardia |
| | FOR in vitro RESEARCH USE ONLY. NOT FOR USE IN HUMANS. |
|
| ||||||||||||||||||||||||||||||||||
| |||||
| For cDNA or Recombinant Protein Search (Input Cat#, Gene name, Protein Name, Accession Number |
|
Copyright Bioclone Inc All rights Reserved